AR105050A1 - Procesos para preparar compuestos antivirales - Google Patents
Procesos para preparar compuestos antiviralesInfo
- Publication number
- AR105050A1 AR105050A1 ARP150101834A ARP150101834A AR105050A1 AR 105050 A1 AR105050 A1 AR 105050A1 AR P150101834 A ARP150101834 A AR P150101834A AR P150101834 A ARP150101834 A AR P150101834A AR 105050 A1 AR105050 A1 AR 105050A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- stereoisomers
- under conditions
- conditions sufficient
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 17
- 238000000034 method Methods 0.000 title abstract 2
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000006242 amine protecting group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 238000006356 dehydrogenation reaction Methods 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462010813P | 2014-06-11 | 2014-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR105050A1 true AR105050A1 (es) | 2017-09-06 |
Family
ID=53783899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150101834A AR105050A1 (es) | 2014-06-11 | 2015-06-10 | Procesos para preparar compuestos antivirales |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US9670187B2 (enExample) |
| EP (1) | EP3154984B1 (enExample) |
| JP (4) | JP6295348B2 (enExample) |
| KR (2) | KR101908642B1 (enExample) |
| CN (1) | CN106488920A (enExample) |
| AR (1) | AR105050A1 (enExample) |
| AU (3) | AU2015274967B2 (enExample) |
| BR (1) | BR112016028773B1 (enExample) |
| CA (1) | CA2951138C (enExample) |
| EA (1) | EA201692219A1 (enExample) |
| ES (1) | ES2690868T3 (enExample) |
| IL (1) | IL248960A0 (enExample) |
| MX (1) | MX2016016297A (enExample) |
| NZ (1) | NZ726356A (enExample) |
| PT (1) | PT3154984T (enExample) |
| SG (1) | SG11201609828SA (enExample) |
| TW (2) | TWI679203B (enExample) |
| WO (1) | WO2015191437A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4032897B1 (en) | 2003-05-30 | 2025-01-29 | Gilead Pharmasset LLC | Modified fluorinated nucleoside analogues |
| TWI548629B (zh) | 2010-11-17 | 2016-09-11 | 吉李德製藥公司 | 抗病毒化合物 |
| PL2635588T3 (pl) | 2011-11-16 | 2015-10-30 | Gilead Pharmasset Llc | Skondensowane imidazoliloimidazole jako związki antywirusowe |
| EP3650014B1 (en) | 2013-08-27 | 2021-10-06 | Gilead Pharmasset LLC | Combination formulation of two antiviral compounds |
| TWI679203B (zh) * | 2014-06-11 | 2019-12-11 | 美商基利法瑪席特有限責任公司 | 製備抗病毒化合物之方法 |
| TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
| WO2016057931A1 (en) | 2014-10-10 | 2016-04-14 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| WO2017060820A1 (en) * | 2015-10-08 | 2017-04-13 | Mylan Laboratories Limited | Process for the preparation of velpatasvir |
| US20190002480A1 (en) * | 2015-12-21 | 2019-01-03 | Merck Sharp & Dohme Corp. | Silane-Containing Heterocyclic Compounds and Methods of Use Thereof for the Treatment of Viral Diseases |
| CN105712969B (zh) * | 2016-01-27 | 2018-07-27 | 杭州科巢生物科技有限公司 | 维帕他韦中间体的合成方法 |
| CN105732765B (zh) * | 2016-02-01 | 2019-07-26 | 杭州科巢生物科技有限公司 | 丙肝药物维帕他韦的新合成方法 |
| CN105732563B (zh) * | 2016-03-23 | 2018-08-28 | 江苏苏利精细化工股份有限公司 | 一种合成9-溴-3-(2-溴乙酰基)-10，11-二氢-5H-二苯并[c,g]色烯-8(9h)-酮的新方法 |
| ES2926579T3 (es) * | 2016-05-05 | 2022-10-27 | Laurus Labs Ltd | Proceso para la preparación de compuestos intermedios útiles en la preparación de inhibidores del virus de la Hepatitis C (VHC) |
| CN109071440A (zh) * | 2016-05-13 | 2018-12-21 | 日产化学株式会社 | 2-乙酰基吡啶化合物的制造方法 |
| CN106220639A (zh) * | 2016-07-22 | 2016-12-14 | 上海众强药业有限公司 | 一种维帕他韦中间体新晶型 |
| CN107573355B (zh) * | 2016-11-30 | 2020-03-17 | 上海博志研新药物技术有限公司 | 维帕他韦、其中间体及制备方法 |
| CN106831737B (zh) * | 2017-02-27 | 2020-03-17 | 上海众强药业有限公司 | 维帕他韦及其衍生物的制备 |
| CN107629029A (zh) * | 2017-09-19 | 2018-01-26 | 安徽省诚联医药科技有限公司 | 维帕他韦中间体的制备方法 |
| CN107501229A (zh) * | 2017-09-27 | 2017-12-22 | 上海泓博智源医药股份有限公司 | 一种维帕他韦中间体的制备方法 |
| CN107987125A (zh) * | 2017-11-23 | 2018-05-04 | 爱斯特（成都）生物制药股份有限公司 | 一种缬氨酸衍生物的制备方法 |
| CN108218755A (zh) * | 2018-01-18 | 2018-06-29 | 上海仁实医药科技有限公司 | 一种N-Boc-4-氧代-L-脯氨酸叔丁酯的合成工艺 |
| CN110835353B (zh) * | 2018-08-15 | 2022-08-19 | 上海茂晟康慧科技有限公司 | 一种艾日布林中间体er804698的合成方法 |
| CN109265431B (zh) * | 2018-10-09 | 2020-05-26 | 江苏苏利精细化工股份有限公司 | 3-乙酰基-10，11-二氢-5h-二苯并[c,g]色烯-8（9h）-酮合成工艺 |
| IT201900018491A1 (it) * | 2019-10-10 | 2021-04-10 | Dr Schaer S P A | Procedimento di purificazione del tris-(3-idrossibutirrato)-gliceril estere |
| IT201900018488A1 (it) * | 2019-10-10 | 2021-04-10 | Dr Schaer S P A | Procedimento di preparazione del tris-(3-idrossibutirrato)-gliceril estere |
| CN111018870B (zh) * | 2019-11-29 | 2021-07-23 | 南京正济医药研究有限公司 | 一种维帕他韦中间体的制备方法 |
| CN112275146B (zh) * | 2020-09-01 | 2021-08-20 | 中国科学院山西煤炭化学研究所 | 一种经磷酸处理的Tröger`s Base聚合物气体分离膜及其制备方法和应用 |
| CN116462627A (zh) * | 2023-04-19 | 2023-07-21 | 南京优氟医药科技有限公司 | 一种3-溴代哌啶-2,6-二酮的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20120993A1 (es) * | 2009-09-04 | 2012-08-22 | Janssen Pharmaceuticals Inc | Derivados bifenilicos como antivirales |
| UA108211C2 (uk) * | 2009-11-04 | 2015-04-10 | Янссен Рід Айрленд | Бензімідазолімідазольні похідні |
| CA2782024A1 (en) * | 2009-11-25 | 2011-06-03 | Schering Corporation | Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
| TWI548629B (zh) | 2010-11-17 | 2016-09-11 | 吉李德製藥公司 | 抗病毒化合物 |
| PL2635588T3 (pl) * | 2011-11-16 | 2015-10-30 | Gilead Pharmasset Llc | Skondensowane imidazoliloimidazole jako związki antywirusowe |
| KR20140145126A (ko) * | 2012-02-13 | 2014-12-22 | 프레시디오 파마슈티칼스, 인코포레이티드 | Hcv ns5a의 저해제를 포함하는 고체형태, 이의 조성물 및 이에 의한 용도 |
| US20130309196A1 (en) * | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
| US9056860B2 (en) * | 2012-06-05 | 2015-06-16 | Gilead Pharmasset Llc | Synthesis of antiviral compound |
| EP3650014B1 (en) | 2013-08-27 | 2021-10-06 | Gilead Pharmasset LLC | Combination formulation of two antiviral compounds |
| TWI679203B (zh) | 2014-06-11 | 2019-12-11 | 美商基利法瑪席特有限責任公司 | 製備抗病毒化合物之方法 |
| TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
-
2015
- 2015-05-28 TW TW104117181A patent/TWI679203B/zh active
- 2015-05-28 TW TW108139659A patent/TW202014413A/zh unknown
- 2015-06-08 KR KR1020177000461A patent/KR101908642B1/ko active Active
- 2015-06-08 BR BR112016028773-8A patent/BR112016028773B1/pt active IP Right Grant
- 2015-06-08 AU AU2015274967A patent/AU2015274967B2/en active Active
- 2015-06-08 CN CN201580031459.0A patent/CN106488920A/zh active Pending
- 2015-06-08 KR KR1020187029248A patent/KR20180114253A/ko not_active Ceased
- 2015-06-08 US US14/733,139 patent/US9670187B2/en active Active
- 2015-06-08 JP JP2016572416A patent/JP6295348B2/ja active Active
- 2015-06-08 CA CA2951138A patent/CA2951138C/en active Active
- 2015-06-08 ES ES15747596.3T patent/ES2690868T3/es active Active
- 2015-06-08 MX MX2016016297A patent/MX2016016297A/es unknown
- 2015-06-08 EA EA201692219A patent/EA201692219A1/ru unknown
- 2015-06-08 WO PCT/US2015/034655 patent/WO2015191437A1/en not_active Ceased
- 2015-06-08 NZ NZ726356A patent/NZ726356A/en not_active IP Right Cessation
- 2015-06-08 SG SG11201609828SA patent/SG11201609828SA/en unknown
- 2015-06-08 PT PT15747596T patent/PT3154984T/pt unknown
- 2015-06-08 EP EP15747596.3A patent/EP3154984B1/en active Active
- 2015-06-10 AR ARP150101834A patent/AR105050A1/es unknown
-
2016
- 2016-11-14 IL IL248960A patent/IL248960A0/en unknown
-
2017
- 2017-04-28 US US15/582,224 patent/US9890134B2/en active Active
- 2017-12-19 US US15/847,803 patent/US20180179175A1/en not_active Abandoned
-
2018
- 2018-01-10 JP JP2018001740A patent/JP2018052985A/ja not_active Withdrawn
- 2018-07-05 AU AU2018204886A patent/AU2018204886B2/en active Active
-
2019
- 2019-05-06 US US16/404,550 patent/US10584109B2/en active Active
- 2019-07-26 JP JP2019137834A patent/JP6954959B2/ja active Active
-
2020
- 2020-01-16 US US16/744,576 patent/US11192875B2/en active Active
- 2020-11-05 AU AU2020264335A patent/AU2020264335B2/en active Active
-
2021
- 2021-08-18 JP JP2021133343A patent/JP2021178872A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR105050A1 (es) | Procesos para preparar compuestos antivirales | |
| AR132627A2 (es) | Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos | |
| CL2018003504A1 (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplasicos. | |
| SV2017005587A (es) | Nuevos derivados hidroxiester, un proceso para su preparacion y composiciones farmaceutacas que los contienen | |
| CO2017012403A2 (es) | Proceso para preparar 4-amino-piridazinas | |
| SV2018005722A (es) | Nuevos derivados de amonio, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| UY36999A (es) | Derivados de aryl oxadiazol fungicidas | |
| MX2020001757A (es) | Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades. | |
| UY36733A (es) | Nuevos derivados aminoácido, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| GT201700189A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
| MX2017001980A (es) | Derivado de quinolina muy puro y metodo para su produccion. | |
| CL2018003474A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
| UY37062A (es) | Derivados de aryl oxadiazol fungicidas | |
| CO2017000337A2 (es) | Derivados de bis(aril)catecol como herbicidas | |
| UY36122A (es) | ?derivados de pirrolidina-2,5-diona, composiciones farmacéuticas y métodos para usar como inhibidores ido1? | |
| MX380239B (es) | Derivados de 4h-pirrol[3,2-c]piridin-4-ona. | |
| EP3693366C0 (en) | METHOD FOR PRODUCING ASK1 INHIBITORS | |
| CO2018005954A2 (es) | Compuestos heteroaromáticos como inhibidores de btk | |
| CO2017008600A2 (es) | Análogos de desacetoxitubulisina h, composiciones y método de producción de los mismos | |
| CO2019007834A2 (es) | Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende | |
| CO2018003367A2 (es) | Benzamidas sustituidas con isoxazolina y análogos como insecticidas | |
| MX381344B (es) | Compuestos antifungicos y procesos para la fabricacion. | |
| CR20170496A (es) | Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones víricas | |
| GT201400167A (es) | Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2 | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |